Research on the genetic architecture of intellectual and developmental disorders have revealed a significant contribution of numerical and structural chromosomal abnormalities, rare point mutations, and trinucleotide repeat expansions. Significant advances in technology to identify these mutations as well as the significant reduction in the time and cost required to perform these tests have led to a rapid change in the recommendations regarding genetic testing. The proper genetic workup, when conducted, can help identify these genetic conditions that, if not for their presence, may not have led to the individual manifesting intellectual developmental disorder (IDD). The current recommended genetic evaluation for children with suspected IDD will be reviewed. Newer genetic testing methods will also be presented along with their diagnostic yields. Common genetic syndromes that the child and adolescent psychiatrist may well encounter will be presented along with their common mental health manifestations as well as common medical comorbidities. Psychopharmacological considerations given these comorbidities will be discussed. 1) Increased genetic testing and advances in genetic testing methods have led to an increase in the number of individuals with IDD diagnosed with genetic syndromes. 2) Technology is advancing rapidly in this field and may rapidly become the diagnostic of choice in the near future. 3) The genetic diagnosis of these individuals, in some cases, leads to better prognostication of treatment response to pharmacotherapies, and psychiatrists should be aware of these results. The fraction of children with IDD with known genetic findings is high enough that child and adolescent psychiatrists are well served to be familiar with the more common genetic syndromes.
Read full abstract